Global HER2 Tumor Marker Testing Market Growth (Status and Outlook) 2026-2032

May 2026 | 105 pages | ID: G1106CF50474EN
LP Information

Abstracts

The global HER2 Tumor Marker Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.

The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.

LPI (LP Information)' newest research report, the “HER2 Tumor Marker Testing Industry Forecast” looks at past sales and reviews total world HER2 Tumor Marker Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected HER2 Tumor Marker Testing sales for 2026 through 2032. With HER2 Tumor Marker Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Tumor Marker Testing industry.

This Insight Report provides a comprehensive analysis of the global HER2 Tumor Marker Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HER2 Tumor Marker Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Tumor Marker Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Tumor Marker Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Tumor Marker Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Tumor Marker Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immunohistochemistry (IHC)
• Fluorescence In Situ Hybridization (FISH)
• Silver In Situ Hybridization (SISH)
• Others

Segmentation by Application:

• Hospitals
• Diagnostic Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Roche
• Thermo Fisher Scientific
• Agilent
• Leica Biosystems
• Biocare Medical
• BioGenex
• Sysmex
• Abnova
• Novartis
• InvivoGen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HER2 Tumor Marker Testing Market Size (2021-2032)
  2.1.2 HER2 Tumor Marker Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for HER2 Tumor Marker Testing by Country/Region (2021, 2025 & 2032)
2.2 HER2 Tumor Marker Testing Segment by Type
  2.2.1 Immunohistochemistry (IHC)
  2.2.2 Fluorescence In Situ Hybridization (FISH)
  2.2.3 Silver In Situ Hybridization (SISH)
  2.2.4 Others
  2.2.5 HER2 Tumor Marker Testing Market Size by Type
    2.2.5.1 HER2 Tumor Marker Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
2.3 HER2 Tumor Marker Testing Segment by Application
  2.3.1 Hospitals
  2.3.2 Diagnostic Laboratories
  2.3.3 Others
  2.3.4 HER2 Tumor Marker Testing Market Size by Application
    2.3.4.1 HER2 Tumor Marker Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)

3 HER2 TUMOR MARKER TESTING MARKET SIZE BY PLAYER

3.1 HER2 Tumor Marker Testing Market Size Market Share by Player
  3.1.1 Global HER2 Tumor Marker Testing Revenue by Player (2021-2026)
  3.1.2 Global HER2 Tumor Marker Testing Revenue Market Share by Player (2021-2026)
3.2 Global HER2 Tumor Marker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HER2 TUMOR MARKER TESTING BY REGION

4.1 HER2 Tumor Marker Testing Market Size by Region (2021-2026)
4.2 Global HER2 Tumor Marker Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER2 Tumor Marker Testing Market Size Growth (2021-2026)
4.4 APAC HER2 Tumor Marker Testing Market Size Growth (2021-2026)
4.5 Europe HER2 Tumor Marker Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa HER2 Tumor Marker Testing Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas HER2 Tumor Marker Testing Market Size by Country (2021-2026)
5.2 Americas HER2 Tumor Marker Testing Market Size by Type (2021-2026)
5.3 Americas HER2 Tumor Marker Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HER2 Tumor Marker Testing Market Size by Region (2021-2026)
6.2 APAC HER2 Tumor Marker Testing Market Size by Type (2021-2026)
6.3 APAC HER2 Tumor Marker Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HER2 Tumor Marker Testing Market Size by Country (2021-2026)
7.2 Europe HER2 Tumor Marker Testing Market Size by Type (2021-2026)
7.3 Europe HER2 Tumor Marker Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HER2 Tumor Marker Testing by Region (2021-2026)
8.2 Middle East & Africa HER2 Tumor Marker Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa HER2 Tumor Marker Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HER2 TUMOR MARKER TESTING MARKET FORECAST

10.1 Global HER2 Tumor Marker Testing Forecast by Region (2027-2032)
  10.1.1 Global HER2 Tumor Marker Testing Forecast by Region (2027-2032)
  10.1.2 Americas HER2 Tumor Marker Testing Forecast
  10.1.3 APAC HER2 Tumor Marker Testing Forecast
  10.1.4 Europe HER2 Tumor Marker Testing Forecast
  10.1.5 Middle East & Africa HER2 Tumor Marker Testing Forecast
10.2 Americas HER2 Tumor Marker Testing Forecast by Country (2027-2032)
  10.2.1 United States Market HER2 Tumor Marker Testing Forecast
  10.2.2 Canada Market HER2 Tumor Marker Testing Forecast
  10.2.3 Mexico Market HER2 Tumor Marker Testing Forecast
  10.2.4 Brazil Market HER2 Tumor Marker Testing Forecast
10.3 APAC HER2 Tumor Marker Testing Forecast by Region (2027-2032)
  10.3.1 China HER2 Tumor Marker Testing Market Forecast
  10.3.2 Japan Market HER2 Tumor Marker Testing Forecast
  10.3.3 Korea Market HER2 Tumor Marker Testing Forecast
  10.3.4 Southeast Asia Market HER2 Tumor Marker Testing Forecast
  10.3.5 India Market HER2 Tumor Marker Testing Forecast
  10.3.6 Australia Market HER2 Tumor Marker Testing Forecast
10.4 Europe HER2 Tumor Marker Testing Forecast by Country (2027-2032)
  10.4.1 Germany Market HER2 Tumor Marker Testing Forecast
  10.4.2 France Market HER2 Tumor Marker Testing Forecast
  10.4.3 UK Market HER2 Tumor Marker Testing Forecast
  10.4.4 Italy Market HER2 Tumor Marker Testing Forecast
  10.4.5 Russia Market HER2 Tumor Marker Testing Forecast
10.5 Middle East & Africa HER2 Tumor Marker Testing Forecast by Region (2027-2032)
  10.5.1 Egypt Market HER2 Tumor Marker Testing Forecast
  10.5.2 South Africa Market HER2 Tumor Marker Testing Forecast
  10.5.3 Israel Market HER2 Tumor Marker Testing Forecast
  10.5.4 Turkey Market HER2 Tumor Marker Testing Forecast
10.6 Global HER2 Tumor Marker Testing Forecast by Type (2027-2032)
10.7 Global HER2 Tumor Marker Testing Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market HER2 Tumor Marker Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott HER2 Tumor Marker Testing Product Offered
  11.1.3 Abbott HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche HER2 Tumor Marker Testing Product Offered
  11.2.3 Roche HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific HER2 Tumor Marker Testing Product Offered
  11.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Agilent
  11.4.1 Agilent Company Information
  11.4.2 Agilent HER2 Tumor Marker Testing Product Offered
  11.4.3 Agilent HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Agilent Main Business Overview
  11.4.5 Agilent Latest Developments
11.5 Leica Biosystems
  11.5.1 Leica Biosystems Company Information
  11.5.2 Leica Biosystems HER2 Tumor Marker Testing Product Offered
  11.5.3 Leica Biosystems HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Leica Biosystems Main Business Overview
  11.5.5 Leica Biosystems Latest Developments
11.6 Biocare Medical
  11.6.1 Biocare Medical Company Information
  11.6.2 Biocare Medical HER2 Tumor Marker Testing Product Offered
  11.6.3 Biocare Medical HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Biocare Medical Main Business Overview
  11.6.5 Biocare Medical Latest Developments
11.7 BioGenex
  11.7.1 BioGenex Company Information
  11.7.2 BioGenex HER2 Tumor Marker Testing Product Offered
  11.7.3 BioGenex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 BioGenex Main Business Overview
  11.7.5 BioGenex Latest Developments
11.8 Sysmex
  11.8.1 Sysmex Company Information
  11.8.2 Sysmex HER2 Tumor Marker Testing Product Offered
  11.8.3 Sysmex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Sysmex Main Business Overview
  11.8.5 Sysmex Latest Developments
11.9 Abnova
  11.9.1 Abnova Company Information
  11.9.2 Abnova HER2 Tumor Marker Testing Product Offered
  11.9.3 Abnova HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Abnova Main Business Overview
  11.9.5 Abnova Latest Developments
11.10 Novartis
  11.10.1 Novartis Company Information
  11.10.2 Novartis HER2 Tumor Marker Testing Product Offered
  11.10.3 Novartis HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Novartis Main Business Overview
  11.10.5 Novartis Latest Developments
11.11 InvivoGen
  11.11.1 InvivoGen Company Information
  11.11.2 InvivoGen HER2 Tumor Marker Testing Product Offered
  11.11.3 InvivoGen HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 InvivoGen Main Business Overview
  11.11.5 InvivoGen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. HER2 Tumor Marker Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. HER2 Tumor Marker Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunohistochemistry (IHC)
Table 4. Major Players of Fluorescence In Situ Hybridization (FISH)
Table 5. Major Players of Silver In Situ Hybridization (SISH)
Table 6. Major Players of Others
Table 7. HER2 Tumor Marker Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global HER2 Tumor Marker Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
Table 10. HER2 Tumor Marker Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global HER2 Tumor Marker Testing Market Size by Application (2021-2026) & ($ millions)
Table 12. Global HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)
Table 13. Global HER2 Tumor Marker Testing Revenue by Player (2021-2026) & ($ millions)
Table 14. Global HER2 Tumor Marker Testing Revenue Market Share by Player (2021-2026)
Table 15. HER2 Tumor Marker Testing Key Players Head office and Products Offered
Table 16. HER2 Tumor Marker Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HER2 Tumor Marker Testing Market Size by Region (2021-2026) & ($ millions)
Table 20. Global HER2 Tumor Marker Testing Market Size Market Share by Region (2021-2026)
Table 21. Global HER2 Tumor Marker Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global HER2 Tumor Marker Testing Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas HER2 Tumor Marker Testing Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas HER2 Tumor Marker Testing Market Size Market Share by Country (2021-2026)
Table 25. Americas HER2 Tumor Marker Testing Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
Table 27. Americas HER2 Tumor Marker Testing Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)
Table 29. APAC HER2 Tumor Marker Testing Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC HER2 Tumor Marker Testing Market Size Market Share by Region (2021-2026)
Table 31. APAC HER2 Tumor Marker Testing Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC HER2 Tumor Marker Testing Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe HER2 Tumor Marker Testing Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe HER2 Tumor Marker Testing Market Size Market Share by Country (2021-2026)
Table 35. Europe HER2 Tumor Marker Testing Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe HER2 Tumor Marker Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa HER2 Tumor Marker Testing Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa HER2 Tumor Marker Testing Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa HER2 Tumor Marker Testing Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of HER2 Tumor Marker Testing
Table 41. Key Market Challenges & Risks of HER2 Tumor Marker Testing
Table 42. Key Industry Trends of HER2 Tumor Marker Testing
Table 43. Global HER2 Tumor Marker Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global HER2 Tumor Marker Testing Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global HER2 Tumor Marker Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global HER2 Tumor Marker Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Abbott Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 48. Abbott HER2 Tumor Marker Testing Product Offered
Table 49. Abbott HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Roche Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 53. Roche HER2 Tumor Marker Testing Product Offered
Table 54. Roche HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 58. Thermo Fisher Scientific HER2 Tumor Marker Testing Product Offered
Table 59. Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Agilent Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 63. Agilent HER2 Tumor Marker Testing Product Offered
Table 64. Agilent HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Agilent Main Business
Table 66. Agilent Latest Developments
Table 67. Leica Biosystems Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 68. Leica Biosystems HER2 Tumor Marker Testing Product Offered
Table 69. Leica Biosystems HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Leica Biosystems Main Business
Table 71. Leica Biosystems Latest Developments
Table 72. Biocare Medical Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 73. Biocare Medical HER2 Tumor Marker Testing Product Offered
Table 74. Biocare Medical HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Biocare Medical Main Business
Table 76. Biocare Medical Latest Developments
Table 77. BioGenex Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 78. BioGenex HER2 Tumor Marker Testing Product Offered
Table 79. BioGenex HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. BioGenex Main Business
Table 81. BioGenex Latest Developments
Table 82. Sysmex Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 83. Sysmex HER2 Tumor Marker Testing Product Offered
Table 84. Sysmex HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Sysmex Main Business
Table 86. Sysmex Latest Developments
Table 87. Abnova Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 88. Abnova HER2 Tumor Marker Testing Product Offered
Table 89. Abnova HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Abnova Main Business
Table 91. Abnova Latest Developments
Table 92. Novartis Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 93. Novartis HER2 Tumor Marker Testing Product Offered
Table 94. Novartis HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. InvivoGen Details, Company Type, HER2 Tumor Marker Testing Area Served and Its Competitors
Table 98. InvivoGen HER2 Tumor Marker Testing Product Offered
Table 99. InvivoGen HER2 Tumor Marker Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. InvivoGen Main Business
Table 101. InvivoGen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. HER2 Tumor Marker Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Tumor Marker Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. HER2 Tumor Marker Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. HER2 Tumor Marker Testing Sales Market Share by Country/Region (2025)
Figure 8. HER2 Tumor Marker Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global HER2 Tumor Marker Testing Market Size Market Share by Type in 2025
Figure 10. HER2 Tumor Marker Testing in Hospitals
Figure 11. Global HER2 Tumor Marker Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 12. HER2 Tumor Marker Testing in Diagnostic Laboratories
Figure 13. Global HER2 Tumor Marker Testing Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. HER2 Tumor Marker Testing in Others
Figure 15. Global HER2 Tumor Marker Testing Market: Others (2021-2026) & ($ millions)
Figure 16. Global HER2 Tumor Marker Testing Market Size Market Share by Application in 2025
Figure 17. Global HER2 Tumor Marker Testing Revenue Market Share by Player in 2025
Figure 18. Global HER2 Tumor Marker Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas HER2 Tumor Marker Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC HER2 Tumor Marker Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe HER2 Tumor Marker Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa HER2 Tumor Marker Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas HER2 Tumor Marker Testing Value Market Share by Country in 2025
Figure 24. United States HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC HER2 Tumor Marker Testing Market Size Market Share by Region in 2025
Figure 29. APAC HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)
Figure 31. China HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe HER2 Tumor Marker Testing Market Size Market Share by Country in 2025
Figure 38. Europe HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa HER2 Tumor Marker Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa HER2 Tumor Marker Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa HER2 Tumor Marker Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries HER2 Tumor Marker Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 57. United States HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 61. China HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 65. India HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 68. France HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 69. UK HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)
Figure 76. Global HER2 Tumor Marker Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global HER2 Tumor Marker Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries HER2 Tumor Marker Testing Market Size 2027-2032 ($ millions)